Skip to main content

Is My Product Recalled?

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Scan How It Works Saved Get Alerts

Menu

Search All Recalls Latest Recalls Scan Barcode Get Alerts

Categories

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Resources

How Recalls Work FAQ Recall Classifications Statistics & Trends About

Your Recalls

Loading...

Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

Home
/
Brands
/
Lloyd Inc. of Iowa

Lloyd Inc. of Iowa Recalls

All product recalls associated with Lloyd Inc. of Iowa.

Get alerts for this brand

Recall Summary

Total Recalls

36

Past Year

0

Class I (Serious)

0

Most Recent

Apr 2013

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 1–20 of 36 recalls

Levothroid 125mcg (Lloyd Inc.) – Quality Control Issues (2013)

cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.

Class IIModerate

FDAApr 1, 2013Nationwide• Lloyd Inc. of Iowa

Lloyd Thyro-Tab 0.150mg (Lloyd Inc.) – Quality Control Issues (2013)

cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.

Class IIModerate

FDAApr 1, 2013Nationwide• Lloyd Inc. of Iowa

Lloyd Thyro-Tab 0.175mg (Lloyd Inc.) – Quality Control Issues (2013)

cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.

Previous

12

Page 1 of 2Next

Class IIModerate

FDAApr 1, 2013Nationwide• Lloyd Inc. of Iowa

Levothroid 200mcg (Lloyd Inc.) – Quality Control Issues (2013)

cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.

Class IIModerate

FDAApr 1, 2013Nationwide• Lloyd Inc. of Iowa

Lloyd Thyro-Tab 0.200mg (Lloyd Inc.) – Quality Control Issues (2013)

cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.

Class IIModerate

FDAApr 1, 2013Nationwide• Lloyd Inc. of Iowa

Levothroid 150mcg (Lloyd Inc.) – Quality Control Issues (2013)

cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.

Class IIModerate

FDAApr 1, 2013Nationwide• Lloyd Inc. of Iowa

Levothroid 88mcg (Lloyd Inc.) – Quality Control Issues (2013)

cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.

Class IIModerate

FDAApr 1, 2013Nationwide• Lloyd Inc. of Iowa

Lloyd Thyro-Tab 0.050mg (Lloyd Inc.) – Quality Control Issues (2013)

cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.

Class IIModerate

FDAApr 1, 2013Nationwide• Lloyd Inc. of Iowa

Levothroid 112mcg (Lloyd Inc.) – Quality Control Issues (2013)

cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.

Class IIModerate

FDAApr 1, 2013Nationwide• Lloyd Inc. of Iowa

Lloyd Thyro-Tab 0.088mg (Lloyd Inc.) – Quality Control Issues (2013)

cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.

Class IIModerate

FDAApr 1, 2013Nationwide• Lloyd Inc. of Iowa

Levothroid 137mcg (Lloyd Inc.) – Quality Control Issues (2013)

cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.

Class IIModerate

FDAApr 1, 2013Nationwide• Lloyd Inc. of Iowa

Lloyd Thyro-Tab 0.112mg (Lloyd Inc.) – Quality Control Issues (2013)

cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.

Class IIModerate

FDAApr 1, 2013Nationwide• Lloyd Inc. of Iowa

Levothroid (Lloyd Inc.) – Quality Control Issues (2013)

cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.

Class IIModerate

FDAApr 1, 2013Nationwide• Lloyd Inc. of Iowa

Levothroid 50mcg (Lloyd Inc.) – Quality Control Issues (2013)

cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.

Class IIModerate

FDAApr 1, 2013Nationwide• Lloyd Inc. of Iowa

Levothroid 175mcg (Lloyd Inc.) – Quality Control Issues (2013)

cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.

Class IIModerate

FDAApr 1, 2013Nationwide• Lloyd Inc. of Iowa

Lloyd Thyro-Tab 0.137mg (Lloyd Inc.) – Quality Control Issues (2013)

cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.

Class IIModerate

FDAApr 1, 2013Nationwide• Lloyd Inc. of Iowa

Lloyd Thyro-Tab 0.100mg (Lloyd Inc.) – Quality Control Issues (2013)

cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.

Class IIModerate

FDAApr 1, 2013Nationwide• Lloyd Inc. of Iowa

Lloyd Thyro-Tab 0.075mg (Lloyd Inc.) – Quality Control Issues (2013)

cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.

Class IIModerate

FDAApr 1, 2013Nationwide• Lloyd Inc. of Iowa

Lloyd Thyro-Tab 0.125mg (Lloyd Inc.) – Quality Control Issues (2013)

cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.

Class IIModerate

FDAApr 1, 2013Nationwide• Lloyd Inc. of Iowa

Levothroid 75mcg (Lloyd Inc.) – Quality Control Issues (2013)

cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.

Class IIModerate

FDAApr 1, 2013Nationwide• Lloyd Inc. of Iowa